Related Experiment Video
Updated: Jul 13, 2025

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Molecular docking analysis of cetuximab with NOTCH signalling pathway targets for oral cancer
Jayanthi Pazhani1, Vishnu Priya Veeraraghavan1, Selvaraj Jayaraman1
1Centre of Molecular Medicine and Diagnostics (COMManD), Department of Biochemistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai-600077, India.
Abstract:
Notch signaling is an evolutionarily ancient mechanism which intricated in cell-cell communication and it plays a crucial role in various developments in malignancies. Inactivating mutations of NOTCH targets are present in about 10 % of cases of squamous cell carcinoma of the skin, oral cavity, and esophagus that rendering it one of the most frequently mutated genes in oral squamous cell carcinoma. Therefore, it is of interest to document the molecular docking analysis of cetuximab with the NOTCH signaling targets such as NOTCH1, NICD, and HES1. These results suggest that targeting the NOTCH signaling with cetuximab might leads to the better outcome for suppression of invasion and metastasis in oral carcinoma.
Insights
Cetuximab may target NOTCH signaling pathways, including NOTCH1, NICD, and HES1, offering potential for oral squamous cell carcinoma treatment. This approach could suppress tumor invasion and metastasis.
Area of Science:
- Molecular biology
- Oncology
- Cell signaling
Background:
- Notch signaling is crucial in cell communication and cancer development.
- NOTCH pathway mutations are common in oral squamous cell carcinoma (OSCC).
Purpose of the Study:
- To investigate the molecular docking of cetuximab with NOTCH signaling targets.
- To explore cetuximab's potential in treating OSCC by targeting NOTCH.
Main Methods:
- Molecular docking analysis was performed.
- Interactions between cetuximab and NOTCH1, NICD, and HES1 were simulated.
Main Results:
- Cetuximab showed potential binding interactions with NOTCH1, NICD, and HES1.
- The findings suggest cetuximab can modulate the NOTCH pathway.
Conclusions:
- Targeting NOTCH signaling with cetuximab may inhibit invasion and metastasis in OSCC.
- Cetuximab presents a potential therapeutic strategy for oral carcinoma.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle

